Skip to content

Clinical trials

Completed Phase 3 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Status: Completed Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20022
20035
20048
20058
200610
20078
20085
200912
201010
20112
20126
20139
20148
20153
20163
20175
20186
20194
20202
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi8
Population Health Research Institute7
Biosense Webster, Inc.5
Texas Cardiac Arrhythmia Research Foundation5
Advanz Pharma3
Astellas Pharma Inc3
Bayer3
Boehringer Ingelheim3
Bristol-Myers Squibb3
Daiichi Sankyo3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation131
Stroke20
Arrhythmias, Cardiac18
Atrial Flutter16
Heart Diseases9
Heart Failure5
Cardiovascular Diseases4
Hemorrhage4
Embolism3
Acute Coronary Syndrome2

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.